Is an Instrumented Spasticity Assessment an Improvement Over Clinical Spasticity Scales in Assessing and Predicting the Response to Integrated Botulinum Toxin Type A Treatment in Children With Cerebral Palsy?

The instrumented spasticity assessment showed higher responsiveness than the clinical scales. The amount of RMS electromyography is considered a promising parameter to predict treatment response.